REBECCA REICHERT: Open Payments
NPI 1609123363 · LA GRANGE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 21 payments from 8 companies in 2025. Trend: 2023 $786 · 2024 $665 · 2025 $1,183
Food & beverage: $1,140Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $262 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $228 |
| Lundbeck LLC | 2 | $193 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| Daiichi Sankyo Inc. | 1 | $120 |
| Iovance Biotherapeutics, Inc. | 1 | $114 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
Products named: VRAYLAR, CAPLYTA, REXULTI, REBLOZYL, DATROWAY, Amtagvi, Auvelity, ENHERTU.
Industry payments across KY — which companies pay providers there.
